🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose is to demonstrate that vasoreactivity of patients with septic s...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT02885168
Treatments Being Tested
The purpose is to determine how Drotrecogin Alfa (activated) will affect pa...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2003-03
Trial ID
NCT00067730
Treatments Being Tested
Recombinant human Activated Protein C (rhAPC) has been shown to reduce the ...
Status
Completed
Location
Academic Medical Center/ University of Amsterdam
Start Date
2008-10
Trial ID
NCT00943267
Treatments Being Tested
The purpose of this study is to test the efficacy of activated Protein C (X...
Status
Terminated
Location
University of California San Francisco at Fresno
Start Date
2005-01
Trial ID
NCT00112164
Treatments Being Tested
The purpose of this study is to evaluate the relative efficacy and safety o...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician
Start Date
2002-12
Trial ID
NCT00049777
Treatments Being Tested
The transparency commission wishes that the laboratory Lilly France sets up...
Status
Completed
Location
For additional information regarding investigative sites for this study, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2008-11
Trial ID
NCT00803231
The purpose of this study is to determine whether continued administration ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2004-06
Trial ID
NCT00190788
Treatments Being Tested
Adult Patients with Severe Sepsis...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2002-11
Trial ID
NCT00568737
Treatments Being Tested
The overall purpose of the study is to determine whether either of the Impr...
Status
Unknown
Location
Emory University School of Medicine
Start Date
2011-10
Trial ID
NCT01486524
The purpose of this placebo-controlled study is to determine if drotrecogin...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2008-03
Trial ID
NCT00604214
Treatments Being Tested